EMPLOYMENT AGREEMENTEmployment Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made by and between Cortendo AB, a Swedish limited liability company registered with the Company Registry (Sw. Bolagsverket) with organization no. 556537-6554 (the “Company”), and A. Brian Davis (“Executive”) as of March 23, 2015 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • Pennsylvania
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made by and between Cortendo AB, a Swedish limited liability company registered with the Company Registry (Sw. Bolagsverket) with organization no. 556537-6554 (the “Company”), and Matthew Pauls (“Executive”) as of August 23, 2014 (the “Effective Date”).
SHARE PURCHASE AGREEMENTShare Purchase Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • New York
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of February, 2015, by and among Cortendo AB, a public limited liability company incorporated and registered in Sweden under the Swedish Companies Act with business organization number 556537-6554 (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
SUBLEASE AGREEMENTSublease Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations
THIS SUBLEASE AGREEMENT (this “Sublease”), dated this 30th day of March, 2015, by and between Insight Pharmaceuticals LLC, a Delaware limited liability company (“Sublessor”), and Cortendo AB Inc., a Swedish corporation (“Sublessee”).
CORTENDO AB INVESTORS’ RIGHTS AGREEMENT February 10, 2015Investors’ Rights Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • New York
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of February, 2015, by and among Cortendo AB, a public limited liability company incorporated and registered in Sweden under the Swedish Companies Act with business organization number 556537-6554 (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
Technology licence agreementTechnology Licence Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • London
Notice details c/o Maples Corporate Services Limited P.O. Box 309, Ugland House George Town, Grand Cayman, KY1-1104 Cayman Islands Email: SLong@Cortendo.com Copy to: Cortendo AB 900 Northbrook Drive Trevose, Pennsylvania 19053 United States of America Email: SLong@Cortendo.com
ASSET PURCHASE AGREEMENT AMONG CORTENDO AB (publ), AND ASPIREO PHARMACEUTICALS LIMITED AND TVM V LIFE SCIENCE VENTURES GMBH & CO. KG (solely in connection with Sections 6.06, 6.08, 9.10 and ARTICLE VII) Dated as of May 14, 2015Asset Purchase Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • Delaware
This ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of May 14, 2015, by and among CORTENDO AB (publ), a Swedish company (“Buyer”), and ASPIREO PHARMACEUTICALS LTD., an Israeli company (“Seller”),and TVM V LIFE SCIENCE VENTURES GMBH & CO. KG, a German limited partnership (“TVM”) (solely in connection with Sections 6.06, 6.08, 9.10 and ARTICLE VII). Buyer and Seller are collectively referred to herein as the “Parties”, and each individually as a “Party”.
LICENSE AGREEMENT BETWEEN BIOPANCREATE, INC. AND CORNELL UNIVERSITY FOR DOCKET No. D-4291 DOCKET No. D-5208 CONTRACT NO. C201142-07297License Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • New York
This agreement (“Agreement”) is made by and between BioPancreate, Inc. a Delaware company having an address at 150 N. Radnor Chester Road, Suite F200, Radnor, Pennsylvania, 19087 (“LICENSEE”) and Cornell University (“Cornell”) as represented by its Cornell Center for Technology Enterprise and Commercialization (“CCTEC”) at 395 Pine Tree Road, Ithaca, NY 14850.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • August 28th, 2015 • Cortendo AB • Pharmaceutical preparations • New York
THIS SHARE PURCHASE AGREEMENT (the “Agreement”), dated as of January 12, 2015, by and among Cortendo AB (publ), a public limited liability company incorporated and registered in Sweden under the Swedish Companies Act with business organization number 556537-6554 (the “Company”), BioPancreate Inc., a Delaware corporation, Cortendo Invest AB, a limited liability company incorporated and registered in Sweden under the Swedish Companies Act with business organization number 556564-0330, and the investors listed on the Schedule of Investors attached hereto as Exhibit A (individually, an “Investor” and, collectively, the “Investors”).
